Multi-omics integration in clinical trials — the simultaneous analysis of genomics, transcriptomics, proteomics, metabolomics, and epigenomic data to comprehensively profile patient biology and enable precision cohort selection — represents the fastest-expanding trial design approach in the global clinical research landscape, with the Omics Based Clinical Trial Market reflecting...